Full Text View
Tabular View
Study Results
Related Studies
Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease
This study has been completed.
Study NCT00609973   Information provided by University of North Carolina, Chapel Hill

First Received on January 24, 2008.   Last Updated on March 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
Recurrence
More general conditions related to this trial
Digestive System Diseases
Disease Attributes
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Pathologic Processes
Interventions listed in this trial
Ciprofloxacin
Placebo
More general drug interventions related to this trial
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of North Carolina, Chapel Hill
Crohn's and Colitis Foundation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services